Vitro Biopharma, Inc. 8-K SEC Filings

Filed On	Filing
22 Jul 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
27 Jun 2024	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
17 May 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
17 Apr 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
23 Jan 2024	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
16 Jan 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
22 Nov 2023	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
19 Jul 2023	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
07 Jul 2023	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
16 Jun 2023	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
08 Jun 2023	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
20 Apr 2023	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
05 Apr 2023	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
21 Mar 2023	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
17 Jan 2023	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
16 Dec 2022	8-K: Non-Reliance on Previously Issued Financial Statements
28 Nov 2022	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
05 Oct 2020	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
05 Oct 2020	8-K: Other Events
09 Jul 2020	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Comments